Risk Of Renal Insufficiency In African-Americans After Radical Nephrectomy For Kidney Cancer
Main Category: Urology / NephrologyArticle Date: 05 Feb 2007 - 7:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
UroToday.com- Recent studies have suggested that nephron sparing surgery is significantly underutilized as a treatment approach, and that radical nephrectomy for renal cell carcinoma (RCC) is associated with a significantly increased risk of renal insufficiency. Race also plays a role in the development of renal disease and it is of significant note that African Americans (AA) have shown an increase in both the incidence and mortality from RCC. AA race is associated with an increased incidence of risk factors associated with the development of renal insufficiency such as hypertension, diabetes mellitus, and obesity. Further, the incidence of end stage renal disease requiring renal replacement is higher in African Americans. Here, the role of race as a risk factor for the development of renal insufficiency following radical nephrectomy for RCC is examined.
In this retrospective study, 22 AA patients undergoing radical nephrectomy were compared to 19 non-AA patients. Mean tumor size for both groups was 8.1 cm (range 3-25). During the time of the study, 6 patients were excluded from analysis; 3 were on dialysis, 2 with creatinine greater than 2.0 at baseline, and 1 who had a renal transplant. The mean preoperative creatinine for the AA patients was 1.3, which was not significantly different from the mean preoperative creatinine of the non-AA patients (1.1, p=0.07). Following radical nephrectomy, the mean postoperative creatinine for AA patients (1.7) was significantly higher than the mean postoperative creatinine for non-AA patients (1.3, p=0.004). In a subset analysis, the authors found that the mean postoperative creatinine was significantly higher for AA patients with hypertension (2.0) when compared with non-AA patients with hypertension (1.4, p=0.002), but there was no difference in postoperative creatinine between AA's and non-AA's that were normotensive (p=0.09).
This study, while composed of very small numbers of patients, highlights the fact that radical nephrectomy can be associated with significant renal morbidity, and this may particularly be amplified in patients of AA descent. When appropriate and feasible, nephron sparing approaches should be utilized to maximize nephron mass while maintaining oncologic control.
Hepps D, Chernoff A
Urologic Oncology: Seminars and Original Investigations: 24(5): 391-395, 2006.
Reviewed by UroToday.com Contributing Editor Christopher G. Wood, MD, FACS
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to:
www.urotoday.com
Copyright © 2006 - UroToday
Visit our urology / nephrology section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/62348.php>
APA
http://www.medicalnewstoday.com/releases/62348.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



